The Role of Age and Comorbidity Interactions in COVID-19 Mortality
Author Information
Author(s): Patrascu Raul, Dumitru Cristina Stefania, Laza Ruxandra, Besliu Razvan Sebastian, Gug Miruna, Zara Flavia, Laitin Sorina Maria Denisa, Guillen-Grima Francisco
Primary Institution: Victor Babes University of Medicine and Pharmacy, Timisoara
Hypothesis
Younger patients with cardiac comorbidities may exhibit a different mortality risk profile compared to older patients and those with pulmonary conditions.
Conclusion
Younger patients with cardiac comorbidities show a protective effect against mortality, while pulmonary conditions increase mortality risk, especially in older patients.
Supporting Evidence
- Cardiac conditions showed significant protective effects against mortality in younger patients.
- Pulmonary comorbidities significantly increased the risk of mortality.
- Age was a significant modifier of the relationship between cardiac conditions and mortality.
Takeaway
This study found that younger people with heart problems might be safer from dying from COVID-19 than older people, especially if they also have lung issues.
Methodology
A retrospective cohort study analyzing 3005 hospitalized COVID-19 patients from 2020 to 2022, using chi-square tests and logistic regression models.
Potential Biases
Potential biases may arise from the single-center design and the retrospective nature of the data collection.
Limitations
The study's retrospective design limits causal inferences and is based on data from a single center, which may affect generalizability.
Participant Demographics
Mean age was 63.4 years, with 52.5% male and 47.5% female patients.
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI for hypertension: 0.57–0.81; for ischemic heart disease: 0.59–0.88; for pulmonary comorbidities: 1.16–1.88.
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website